Specifically, it was found that the upregulation of Rasgrp1 was associated with an improved overall survival in breast cancer [107], as well as overall survival and disease-free survival in the triple-negative breast cancer subtype [107,108]. The gene discussed is RASGRP1; the disease is breast cancer.